This report supplies information on the Active Pharmaceutical Ingredients Italian market and its competitors: market trends, SWOT and key success factors analysis, major companies performance indicators (total turnover, sector specific turnover, market shares and export quotas), business prospects and trends. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/active-pharmaceutical-ingredients-in-italy.html
 
 Scope
 This report provides an overview of basic pharmaceutical products, also known as APIs (Active Pharmaceutical Ingredients).
 • Product technology: active pharmaceutical ingredients are produced by chemical synthesis, semi-synthesis, fermentation or extraction.
 • Use: APIs are used in the production of pharmaceutical specialities.
 • Client groups: pharmaceutical companies producing specialities under their own brand names or producing equivalent (generic) pharmaceuticals. Marketing Research Report
 
 The analysis excludes the following product categories: raw materials and intermediate materials; active ingredients for captive use by pharmaceutical companies in the speciality medicines segment; active ingredients for cosmetic or dietary use; pharmaceutical substances used as raw material in the formulation of specialities but without specific therapeutic or preventive activity; substances used as contrast medium; medicinal specialities; animal organ extracts leading directly to preventive specialities, such as serums and vaccines; plant extracts destined for other segments, such as dietary or cosmetic products.
 
 Segments
 The report analyses the following business lines:
 • Antibiotics (cephalosporin, penicillin and others);?
 • Synthetic ingredients (non-antibiotics);?
 • Steroids (derived from hormonal substances);?
 • Organomedicines (extracts from organs or hormones of animal origin);
 • Phytomedicines: (plant extracts).
 
 Methodology
 In order to draw up the Competitors report, the Databank method foresees the screening of the main realities of the sectors and various one-to-one interviews with the selected players. All this is then completed via:
 - the gathering of information questionnaires that are filled out by the main companies on an annual basis;
 - the checking of the gathered information by a sector expert, using a verification system that guarantees maximum reliability and consistency;
 - the processing of information belonging to the Cerved Group about Italian economic realities.
 
 The strategies and performances of the largest players in each sector are looked at in dept in the Competitors report. In all the cases in which a specific source is not indicated, the information published in the report must be intended as extracted and processed from the Cerved Group's proprietary information. Each sector addressed in the Competitors products may be the subject of a dedicated presentation in the company or developed during a training course on the same subject.
 
 Companies Mentioned
 A. COSTANTINO & C. SPA
 ABC FARMACEUTICI SPA
 ACS DOBFAR SPA
 AMSA SPA
 ARCHIMICA SRL
 BIDACHEM SPA
 BIOFER SPA
 BIOINDUSTRIA LIM SPA
 CAMBREX PROFARMACO MILANO SRL
 CHEMI SPA
 COSMA SPA
 DIPHARMA FRANCIS SPA
 DSM CAPUA SPA
 ERREGIERRE SPA
 EUTICALS SPA
 F.I.S. FABBRICA ITALIANA SINTETICI SPA
 FARCHEMIA SRL
 FARMABIOS SRL
 FIDIA FARMACEUTICI SPA
 FLAMMA SPA SPA
 INDENA SPA SPA
 INFA LABOCHIM SPA
 ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI SPA
 L.D.O. LABORATORIO DERIVATI ORGANICI SPA
 LUSOCHIMICA SPA
 NATUREX SPA
 NEWCHEM SPA
 OLON SPA
 OPOCRIN SPA
 P. & R. SPA
 PROCOS SPA
 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
 SANDOZ INDUSTRIAL PRODUCTS SPA
 SICOR SOCIETA' ITALIANA CORTICOSTEROIDI SRL
 SIFAVITOR SRL
 SOCIETA' ITALIANA MEDICINALI SCANDICCI - S.I.M.S. SRL
 STERLING SRL SRL
 STEROID SRL
 TEVA P.F.C. SRL
 ZACH SYSTEM SPA
 
 For more information kindly visit :
 Active Pharmaceutical Ingredients in Italy
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B